27.13
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Reach Out - ACCESS Newswire
Mackenzie Financial Corp Raises Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics launches HYDROS system in UK By Investing.com - Investing.com India
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 65.40% - GuruFocus
PROCEPT BioRobotics launches HYDROS system in UK - Investing.com South Africa
Insider Selling: PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells 3,243 Shares of Stock - MarketBeat
Procept BioRobotics announces international Hydros robot launch - MassDevice
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Procept BioRobotics announce international launch of HYDROS Robotic - TipRanks
Procept Biorobotics Announces International Launch of the Hydros Robotic System, Expanding Global Access to Ai-Enabled Aquablation Therapy - marketscreener.com
PROCEPT BioRobotics Overcomes S-Curve Challenge as HYDROS Seeks Rapid Expansion of BPH Treatments - Bitget
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.2%Time to Buy? - MarketBeat
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - marketscreener.com
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
[144] PROCEPT BioRobotics Corp SEC Filing - Stock Titan
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Benzinga
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Insider Buying Activity - MarketBeat
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)? - simplywall.st
Major Insider Shake-Up at PROCEPT BioRobotics as Top Executives Trade Shares - TipRanks
Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Nigeria
Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
PROCEPT BioRobotics (NASDAQ:PRCT) Director Antal Rohit Desai Purchases 167,246 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Director Buys $3,781,878.03 in Stock - MarketBeat
Insider Buying: PROCEPT BioRobotics (NASDAQ:PRCT) Director Acquires 98,699 Shares of Stock - MarketBeat
Kevin Waters Sells 6,721 Shares of PROCEPT BioRobotics (NASDAQ:PRCT) Stock - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells $163,340.40 in Stock - MarketBeat
Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares - Investing.com India
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Blair William & Co. IL Purchases 169,237 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Adds Independent Director to Audit Committee - The Globe and Mail
Baird Initiates Coverage of PROCEPT BioRobotics (PRCT) with Neutral Recommendation - Nasdaq
Baird initiates Procept BioRobotics stock rating at Neutral By Investing.com - Investing.com India
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 6.9%Time to Sell? - MarketBeat
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Robert W. Baird Initiates Coverage on PROCEPT BioRobotics (NASDAQ:PRCT) - MarketBeat
Procept Biorobotics Corporation Appoints Daniel Puckett Board and Audit Committee Member, Effective March 5, 2026 - marketscreener.com
PRCT: Baird Initiates Neutral Rating with $30 Price Target | PRC - GuruFocus
Procept BioRobotics appoints Daniel Puckett to board and audit committee - Investing.com
Procept BioRobotics initiated with a Neutral at Baird - TipRanks
A Look At PROCEPT BioRobotics (PRCT) Valuation After Earnings Miss And New 2026 To 2027 Guidance - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - PR Newswire
Procept BioRobotics Balances Rapid Growth With Profit Push - TipRanks
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $19.35 - Markets Mojo
PROCEPT BioRobotics Stock Hits Day Low of $19.35 Amid Price Pressure - Markets Mojo
PROCEPT BioRobotics Faces Weak Start with 30.5% Gap Down Amid Market Concerns - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Sells 56,967 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Champlain Investment Partners LLC Grows Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Citigroup Inc. Purchases 45,979 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects - 富途牛牛
PROCEPT BioRobotics (+14%): Cowen Conference Rebound After Earnings Sell-Off - Trefis
PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics - DirectorsTalk Interviews
William Blair Investment Management LLC Purchases 54,396 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Vanguard Group Inc. Sells 42,630 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):